RNA Binding Motif Protein 39 (RBM39) Antikörper

Antigen: RNA Binding Motif Protein 39 (RBM39)

Synonyme: HCC1, CAPER, CC1.3, RNPC2, fSAP59, FLJ44170, CAPERalpha, DKFZp781C0423, Rnpc2, caper, C79248, R75070, 1500012C14Rik, 2310040E03Rik, B330012G18Rik, MGC109490, RBM39, Rbm39, ACYPI002389, DKFZp459F148

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human, Maus

Applikation: Western Blot (WB), Immunpräzipitation (IP)

Produktnummer: ABIN223403

Produktbeschreibung

Weitere Bezeichnung: Caper

Gen-ID: 9584

Immunogen: Synthetic peptide of human Caper

Format: Affinity-purified

Beschreibung: 100 ul affinity purified rabbit polyclonal antibody. Reacts with human/mouse. Tested in Western Blot and immunoprecipitation. Synonyms: Caper Polyclonal Antibody, Anti-Caper Polyclonal antibody, Caper antibody, Anti-Caper, Caper, RNPC2, RNA-binding region containing protein 2, Coactivator of activating protein-1 and estrogen receptors, HCC1, Hepatocellular carcinoma protein 1, Splicing factor CC1.3, Splicing factor CC1.4 Synonyms: Caper Polyclonal Antibody, Anti-Caper Polyclonal antibody, Caper antibody, Anti-Caper, Caper, RNPC2, RNA-binding region containing protein 2, Coactivator of activating protein-1 and estrogen receptors, HCC1, Hepatocellular carcinoma protein 1, Splicing factor CC1.3, Splicing factor CC1.4

Anwendungen

Applikationshinweise: The antibody can be used in Western blotting (1:500

Buffer: 100 ulaffinity purified rabbit polyclonal antibody in phosphate-buffered saline (PBS) containing 30% glycerol, 0.5% BSA and 0.01% thimerosal.

Lagerung: Store at -20 o C. For long term storage, aliquot and freeze at

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Sotgia, Del Galdo, Casimiro et al.: "Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts." in: The American journal of pathology, Vol. 174, Issue 3, pp. 746-61, 2009 (PubMed).

Mercier, Casimiro, Zhou et al.: "Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions." in: The American journal of pathology, Vol. 174, Issue 4, pp. 1172-90, 2009 (PubMed).